Literature DB >> 29344479

Mechanisms of Optic Nerve Invasion in Primary Choroidal Melanoma.

Eszter Szalai1, Jill R Wells1, Hans E Grossniklaus1,2.   

Abstract

AIM: The aim of this study was to assess morphological risk factors associated with optic nerve invasion of choroidal melanoma and to identify possible mechanisms of optic nerve invasion.
METHODS: Medical charts and histology slides of patients with primary choroidal melanoma who were treated by enucleation/exenteration and whose pathology showed optic nerve invasion were reviewed.
RESULTS: Twenty-one patients (mean age: 65.67 ± 14.72 years) with primary uveal melanoma arising from the choroid were included in this analysis. A peripapillary location was present in 86% of the cases. Four types of optic nerve invasion were identified: transvitreal invasion (10%); retinal invasion (23%); direct peripapillary invasion (57%); and a combined mechanism (10%). Optic nerve invasion was prelaminar in 67%, laminar in 10%, and retrolaminar in 23% of the cases. Significantly higher largest basal diameter (p = 0.021) and tumor thickness values (p = 0.017) and higher rates of vortex vein (p = 0.022) and retinal invasion (p = 0.007) were observed in the transvitreal/retinal invasion groups when compared to the direct peripapillary invasion group.
CONCLUSIONS: A peripapillary tumor location was the most common mechanism of optic nerve invasion of choroidal melanoma. In 43% of the cases, other mechanisms including transvitreal and retinal invasion resulted in optic nerve invasion.

Entities:  

Keywords:  Choroidal melanoma; Enucleation; Optic nerve invasion; Peripapillary melanoma; Retinal invasion; Vitreous seeding

Year:  2017        PMID: 29344479      PMCID: PMC5757616          DOI: 10.1159/000456718

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  28 in total

1.  MALIGNANT MELANOMAS OF THE UVEA IN DENMARK 1943-1952. A CLINICAL, HISTOPATHOLOGICAL, AND PROGNOSTIC STUDY.

Authors:  O A JENSEN
Journal:  Acta Ophthalmol (Copenh)       Date:  1963

Review 2.  Retinoinvasive malignant melanoma of the uvea.

Authors:  T Kivelä; P Summanen
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

3.  Optic nerve invasion of uveal melanoma.

Authors:  Jens Lindegaard; Peter Isager; Jan Ulrik Prause; Steffen Heegaard
Journal:  APMIS       Date:  2007-01       Impact factor: 3.205

4.  Small choroidal melanoma with massive extraocular extension: invasion through posterior scleral emissary channels.

Authors:  R Sambuelli; J D Luna; V E Reviglio; A Aoki; C P Juarez
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

5.  Features of Cutaneous Malignant Melanoma Metastatic to the Retina and Vitreous.

Authors:  Mark P Breazzano; Ann E Barker-Griffith
Journal:  Ocul Oncol Pathol       Date:  2015-09-22

6.  Cytology of metastatic cutaneous melanoma to the vitreous and retina.

Authors:  C W Spraul; D F Martin; W S Hagler; H E Grossniklaus
Journal:  Retina       Date:  1996       Impact factor: 4.256

7.  Peripapillary choroidal melanomas. Extension along the optic nerve and its sheaths.

Authors:  H F Shammas; F C Blodi
Journal:  Arch Ophthalmol       Date:  1978-03

8.  Retinal metastasis from systemic cancer in 8 cases.

Authors:  Carol L Shields; Jeffrey F McMahon; Hatice T Atalay; Murat Hasanreisoglu; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2014-11       Impact factor: 7.389

9.  Pseudoretinitis pigmentosa secondary to preretinal malignant melanoma cells.

Authors:  R C Eagle; J A Shields
Journal:  Retina       Date:  1982       Impact factor: 4.256

10.  A case of cutaneous melanoma metastatic to the vitreous cavity: possible pathomechanism and review of the literature.

Authors:  Gesine B Jaissle; Peter Szurman; Jens Martin Rohrbach; Faik Gelisken; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.535

View more
  1 in total

1.  Optic nerve invasion of non-juxtapapillary uveal melanoma: a rare occurrence.

Authors:  Abhimanyu Sharma; Dilip K Mishra; Swathi Kaliki
Journal:  BMJ Case Rep       Date:  2020-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.